Grant: COVID-19 Recommendations & Contextualization (eCOVID19RecMap) Extension
McMaster University
$999,984.00
COVID-19 Recommendations and Contextualization (eCOVID19RecMap) Extension
EF 2022-23
Résumé
Background
and Importance.
With a competitive grant, awarded by CIHR in 2020, we brought together a
network of 60 partners including a notable list of major international
and national guideline developers to contribute to Canada’s global
response to the COVID-19 outbreak. We built the interactive and open
access COVID-19 Living Map of Recommendations and Gateway to
Contextualization (referred to as the RecMap: https://covid19.recmap.org)
which collates and presents quality-appraised clinical, public health
and health policy guidelines. The RecMap has been the source for
contextualized decisions at the local, provincial, and national level
(e.g., Brazil, Slovakia, India). It serves as a template for similar
efforts (e.g., by the World Health Organization). Since the RecMap’s
launch, over 22,000 global users have visited the site in more than
37,000 sessions with over 141,000 page views and, in addition to
dissemination through publications by users and partners, we published
peer-reviewed articles. Maintenance and continued development of the
RecMap is critical for many reasons such as: 1) uncertainty about the
emergence of new virus variants and about future impact of vaccines; 2)
unknown consequences on physical and mental health (e.g., long
COVID-19); and 3) low credibility of many guidelines.
Research
Aims.
Our objectives for this next phase include:
1.
To
retain the currency of the RecMap;
2.
To
mobilize knowledge about COVID-19 recommendations across multiple
stakeholders, with a particular focus on addressing health inequities;
and
3.
To
further innovate and evaluate recommendation mapping as a method and
concept to prepare for other health problems and emergencies.
Methods
and Approaches.
We will sustain our newly developed systematic process of searching,
screening, critically appraising, and extracting recommendations. We
will support their contextualization and uptake for all people with new
and existing partners (e.g., policymakers, clinicians and diverse
patient groups such as Indigenous, migrants and refugees), particularly
the public health sector in Canada to optimize the reach of the RecMap.
One approach is to co-design strategies to overcome barriers, enhance
communication, and develop priorities, through a health equity-oriented
use of the RecMap. To enhance further uptake, we will systematically
conduct usability testing with diverse audiences and pilot the
integration in electronic health records. We will enhance our new
approaches to create plain language recommendations (PLRs) in many
languages. PLRs allow the public and media to benefit from easy-to-read,
accessible and unbiased recommendations. Finally, we will evaluate our
work, so that the RecMap serves as a model for the future.
Expertise.
Under leadership of the World Health Organization (WHO) Collaborating
Centre for Infectious Diseases, Research Methods and Recommendations and
Cochrane at McMaster University, the team from across Canada, Australia,
Brazil, Cameroon, Chile, Czech Republic, Germany, India, Lebanon,
Norway, Slovakia, South Africa, Spain, and USA has strong expertise
related to COVID-19, knowledge synthesis, living recommendations,
capacity-building, and health equities, and content relevant to specific
populations (e.g., children, long-term care clients, refugees,
Indigenous).
Expected
outcomes.
We will produce an enhanced RecMap that provides real-time evidence
to inform decision-makers, including in low- and-middle income settings
and from clinical, public health and health policy perspectives, which
is enriched by facilitating contextualization. Based on our
learnings, we will also develop guidance for how to engage
stakeholders in RecMaps and creating equity-oriented PLRs.
Partners
and collaborators.
We are grateful for our strong partnerships with the Guidelines
International Network, the Public Health Agency of Canada, various WHO
offices, the National Institute for Health and Care Excellence (NICE) in
the UK and many others.
Programme
COVID-19 Recommendations & Contextualization (eCOVID19RecMap) Extension
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
465991
Name
Schunemann Holger J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
COVID-19 Recommendations & Contextualization (eCOVID19RecMap) Extension
Projecttitle
COVID-19 Recommendations and Contextualization (eCOVID19RecMap) Extension
Programtype2
Directed Grant
Orgnameinp2
McMaster University
Cihramount2
$999,984
Cihrequipment2
$0
Programname2
COVID-19 Recommendations & Contextualization (eCOVID19RecMap) Extension
Keyworddelim
Covid-19
Competitiondate
202205
Approvedterm2
1 yr 0 mth
Pinamesdelim
Schunemann, Holger J; Akl, Elie A; Butcher, Nancy J; Falavigna, Maicon; Hartling, Lisa A; Klugar, Miloslav; Kredo, Tamara; Mathew, Joseph L; Offringa, Martin; Piggott, Thomas W; Pottie, Kevin; Richards, Dawn; Suvada, Jozef
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $999,984~ $0~
Abstract
<html>
<head>
</head>
<body>
<p class="MsoNormal" style="margin-top: 6.0pt; margin-right: 0in; margin-bottom: 0in; margin-left: 0in; line-height: normal">
<i><span lang="EN-CA"><font size="12.0pt" face="Garamond,serif">Background
and Importance</font></span></i><span lang="EN-CA"><font size="12.0pt" face="Garamond,serif">.
With a competitive grant, awarded by CIHR in 2020, we brought together a
network of 60 partners including a notable list of major international
and national guideline developers to contribute to Canada’s global
response to the COVID-19 outbreak. We built the interactive and open
access <b>COVID-19 Living Map of Recommendations and Gateway to
Contextualization</b> (referred to as the RecMap: </font></span><font size="12.0pt" face="Garamond,serif"><span><a href="https://covid19.recmap.org">https://covid19.recmap.org</a></span><span lang="EN-CA">)
which collates and presents quality-appraised clinical, public health
and health policy guidelines. The RecMap has been the source for
contextualized decisions at the local, provincial, and national level
(e.g., Brazil, Slovakia, India). It serves as a template for similar
efforts (e.g., by the World Health Organization). Since the RecMap’s
launch, over 22,000 global users have visited the site in more than
37,000 sessions with over 141,000 page views and, in addition to
dissemination through publications by users and partners, we published
peer-reviewed articles. Maintenance and continued development of the
RecMap is critical for many reasons such as: 1) uncertainty about the
emergence of new virus variants and about future impact of vaccines; 2)
unknown consequences on physical and mental health (e.g., long
COVID-19); and 3) low credibility of many guidelines.
</span></font> </p>
<p class="MsoNormal" style="margin-top: 6.0pt; margin-right: 0in; margin-bottom: 0in; margin-left: 0in; line-height: normal">
<i><span lang="EN-CA"><font size="12.0pt" face="Garamond,serif">Research
Aims</font></span></i><font size="12.0pt" face="Garamond,serif"><span lang="EN-CA">.
Our objectives for this next phase include: </span></font>
</p>
<p class="MsoListParagraphCxSpFirst" style="margin-top: 0in; margin-right: 0in; margin-bottom: 0in; margin-left: 21.3pt; text-indent: -14.2pt; line-height: normal">
<span><font size="12.0pt" face="Garamond,serif">1.</font></span><span style="font-variant: normal; line-height: normal"><font size="7.0pt" face="Times New Roman">  
</font></span><span lang="EN-CA"><font size="12.0pt" face="Garamond,serif">To
retain the currency of the RecMap;</font></span>
</p>
<p class="MsoListParagraphCxSpMiddle" style="margin-top: 6.0pt; margin-right: 0in; margin-bottom: 0in; margin-left: 21.3pt; text-indent: -14.2pt; line-height: normal">
<span><font size="12.0pt" face="Garamond,serif">2.</font></span><span style="font-variant: normal; line-height: normal"><font size="7.0pt" face="Times New Roman">  
</font></span><span lang="EN-CA"><font size="12.0pt" face="Garamond,serif">To
mobilize knowledge about COVID-19 recommendations across multiple
stakeholders, with a particular focus on addressing health inequities;
and</font></span>
</p>
<p class="MsoListParagraphCxSpLast" style="margin-top: 6.0pt; margin-right: 0in; margin-bottom: 0in; margin-left: 21.3pt; text-indent: -14.2pt; line-height: normal">
<span><font size="12.0pt" face="Garamond,serif">3.</font></span><span style="font-variant: normal; line-height: normal"><font size="7.0pt" face="Times New Roman">  
</font></span><span lang="EN-CA"><font size="12.0pt" face="Garamond,serif">To
further innovate and evaluate recommendation mapping as a method and
concept to prepare for other health problems and emergencies.</font></span>
</p>
<p class="MsoNormal" style="margin-top: 6.0pt; margin-right: 0in; margin-bottom: 0in; margin-left: 0in; line-height: normal">
<i><span lang="EN-CA"><font size="12.0pt" face="Garamond,serif">Methods
and Approaches</font></span></i><font size="12.0pt" face="Garamond,serif"><span lang="EN-CA">.
We will sustain our newly developed systematic process of searching,
screening, critically appraising, and extracting recommendations. We
will support their contextualization and uptake for all people with new
and existing partners (e.g., policymakers, clinicians and diverse
patient groups such as Indigenous, migrants and refugees), particularly
the public health sector in Canada to optimize the reach of the RecMap.
One approach is to co-design strategies to overcome barriers, enhance
communication, and develop priorities, through a health equity-oriented
use of the RecMap. To enhance further uptake, we will systematically
conduct usability testing with diverse audiences and pilot the
integration in electronic health records. We will enhance <b>our new
approaches to create plain language recommendations (PLRs)</b> in many
languages. PLRs allow the public and media to benefit from easy-to-read,
accessible and unbiased recommendations. Finally, we will evaluate our
work, so that the <b>RecMap serves as a model for the future</b>.</span></font>
</p>
<p class="MsoNormal" style="margin-top: 6.0pt; margin-right: 0in; margin-bottom: 0in; margin-left: 0in; line-height: normal">
<i><span lang="EN-CA"><font size="12.0pt" face="Garamond,serif">Expertise</font></span></i><font size="12.0pt" face="Garamond,serif"><span lang="EN-CA">.
Under leadership of the World Health Organization (WHO) Collaborating
Centre for Infectious Diseases, Research Methods and Recommendations and
Cochrane at McMaster University, the team from across Canada, Australia,
Brazil, Cameroon, Chile, Czech Republic, Germany, India, Lebanon,
Norway, Slovakia, South Africa, Spain, and USA has strong expertise
related to COVID-19, knowledge synthesis, living recommendations,
capacity-building, and health equities, and content relevant to specific
populations (e.g., children, long-term care clients, refugees,
Indigenous). </span></font>
</p>
<p class="MsoNormal" style="margin-top: 6.0pt; margin-right: 0in; margin-bottom: 0in; margin-left: 0in; line-height: normal">
<i><span lang="EN-CA"><font size="12.0pt" face="Garamond,serif">Expected
outcomes</font></span></i><font size="12.0pt" face="Garamond,serif"><span lang="EN-CA">.
We will produce an enhanced <b>RecMap that provides real-time evidence
to inform decision-makers, including in low- and-middle income settings
and from clinical, public health and health policy perspectives, which
is enriched by facilitating contextualization</b>. Based on our
learnings, we will also develop guidance for how to <b>engage
stakeholders in RecMaps and creating equity-oriented PLRs</b>.
</span></font> </p>
<p class="MsoNormal" style="margin-top: 6.0pt; margin-right: 0in; margin-bottom: 0in; margin-left: 0in; line-height: normal">
<i><span lang="EN-CA"><font size="12.0pt" face="Garamond,serif">Partners
and collaborators</font></span></i><font size="12.0pt" face="Garamond,serif"><span lang="EN-CA">.
We are grateful for our strong partnerships with the <b>Guidelines
International Network, the Public Health Agency of Canada, various WHO
offices, the National Institute for Health and Care Excellence (NICE) in
the UK</b> and many others.</span></font>
</p>
</body>
</html>